Researchers sought to determine whether certain subtypes of UBA1 mutations impacted survival outcomes in patients with VEXAS syndrome.
Jonathan Goodman, MPhil
Jonathan was the editor of Cancer Therapy Advisor from 2016 to 2018. His work has appeared in Aeon Magazine, The Week, and The Guardian, among other publications.